Draw/line
Home / Compounds / GHK-Cu

GHK-Cu

GHK-Cu: the difference between topical and injectable use, FDA status and what human evidence exists.

Not FDA-approved · Evidence grade D · Reviewed

GHK-Cu (Copper tripeptide). Copper-binding peptide.

DNot FDA-approved. Evidence grade D: animal and lab data only.

What is GHK-Cu?

GHK-Cu is a small copper-binding peptide used in skin-care products and, more recently, sold for injection.

Is GHK-Cu FDA-approved?

Not approved as a drug. FDA flagged the injectable form in 2023. An advisory committee review is expected before the end of February 2027.

What does the evidence show for GHK-Cu?

Some human evidence for topical use on skin. No human studies support injecting it.

What are the known risks of GHK-Cu?

FDA has cited a risk of immune reactions with injectable products because of possible aggregation and impurities.

How is GHK-Cu measured?

Products sold online as "research use only" have no assurance of identity, dose or sterility. The calculator can do the arithmetic for any vial, but it cannot tell you what is actually in one.

Sources: FDA: bulk drug substances that may present significant safety risks; Worst Pills, Best Pills: unapproved peptides. This profile does not recommend any dose or use.

For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.